Infanrix Quinta Drug Information [ GlaxoSmithKline ]

Table of content

Infanrix Quinta category:

• Human

Active ingredients:

• Bordetella Pertussis Antigens
• Bordetella Pertussis Toxoid
• Diphtheria Toxoid
• Filamentous Haemagglutinin Bordetella Pertussis
• Haemophilus Influenzae Type B Polysaccharide
• Pertactin
• Poliomyelitis Virus Type 1 Inactivated
• Poliomyelitis Virus Type 2 Inactivated
• Poliomyelitis Virus Type 3 Inactivated
• Polyoside Haemophilus Influenzae Type B Tetanus Protein
• Tetanus Toxoid

Infanrix Quinta companies and manufacturers:

• GlaxoSmithKline

General Information

Infanrix Quinta forms, composition and dosages:

• Injectable; Injection; Bordetella Pertussis Antigens 58 mcg; Bordetella Pertussis Toxoid 25 mcg; Diphtheria Toxoid 30 IU; Filamentous Haemagglutinin Bordetella pertussis 25 mcg; Haemophilus Influenzae Type B Polysaccharide 10 mcg; Pertactin 8 mcg; Poliomyelitis Virus Type 1 Inactivated 40 UD; Poliomyelitis Virus Type 2 Inactivated 40 UD; Poliomyelitis Virus Type 3 Inactivated 40 UD; Polyoside Haemophilus Influenzae Type B Tetanus Protein 40 mcg; Tetanus Toxoid 40 IU / 0.5 ml

Indications, usages and classification codes:

• ATC
• ICD-10

• Infanrix Quinta analogs
• Infanrix Quinta similar